Factors influencing the absorption and disposition of mecillinam and pivmecillinam in man
- PMID: 22216505
- PMCID: PMC1428919
- DOI: 10.1111/j.1365-2125.1976.tb04886.x
Factors influencing the absorption and disposition of mecillinam and pivmecillinam in man
Abstract
In a pharmacokinetic study in six volunteers peak serum mecillinam concentrations were proportional to the oral dose of pivmecillinam at two dose levels of 200 and 400 mg. Effects of bed rest, probenecid and a 6 day course of treatment with pivmecillinam on serum mecillinam concentrations after an oral dose of pivmecillinam (two 200 mg capsules) have been investigated. Resting subjects had lower peak serum levels and a decreased rate of clearance than moderately active subjects, changes which are similar to those previously reported for benzylpenicillin. Pretreatment with probenecid produced significantly higher serum mecillinam levels, a longer serum antibiotic half-life and a decreased rate of drug clearance which suggests that mecillinam is actively excreted by kidney tubules. Plasma mecillinam level profiles obtained after the first dose of a 6 day treatment period were not significantly different from corresponding values after the first dose on the seventh day which indicates that each dose of mecillinam is eliminated in healthy young adults before succeeding doses are taken.
Similar articles
-
Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers.Eur J Clin Pharmacol. 1982;23(3):249-52. doi: 10.1007/BF00547563. Eur J Clin Pharmacol. 1982. PMID: 6293834 Clinical Trial.
-
Amdinocillin.2023 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 37247367 Free Books & Documents. Review.
-
Pivmecillinam--therapy of choice for lower urinary tract infection.Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:73-8. doi: 10.1016/s0924-8579(03)00235-8. Int J Antimicrob Agents. 2003. PMID: 14527775 Review.
-
The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women.Br J Clin Pharmacol. 1992 Jun;33(6):629-33. doi: 10.1111/j.1365-2125.1992.tb04092.x. Br J Clin Pharmacol. 1992. PMID: 1389936 Free PMC article.
-
Urinary excretion of mecillinam by volunteers receiving film-coated tablets of pivmecillinam hydrochloride.Chemotherapy. 1979;25(1):1-4. doi: 10.1159/000237814. Chemotherapy. 1979. PMID: 217572 Clinical Trial.
Cited by
-
Safety, pharmacokinetics, and food-effect of pivmecillinam after single- and multiple-dose in healthy Chinese subjects: a phase I study.Naunyn Schmiedebergs Arch Pharmacol. 2024 May 1. doi: 10.1007/s00210-024-03118-3. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38691150
-
Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature.Br J Pharmacol. 2022 Jun;179(11):2538-2557. doi: 10.1111/bph.15822. Epub 2022 Mar 15. Br J Pharmacol. 2022. PMID: 35170019 Free PMC article. Review.
-
Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.BMC Infect Dis. 2016 Nov 3;16(1):620. doi: 10.1186/s12879-016-1797-3. BMC Infect Dis. 2016. PMID: 27806687 Free PMC article.
-
Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers.Eur J Clin Pharmacol. 1982;23(3):249-52. doi: 10.1007/BF00547563. Eur J Clin Pharmacol. 1982. PMID: 6293834 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources